Open AccessPolymorphisms in microRNA let-7 binding sites of the HIF1AN and CLDN12 genes can predict pathologic complete response to taxane- and platinum-based neoadjuvant chemotherapy in breast cancer
Author(s) -
Yueyao Du,
Liheng Zhou,
Yingsong Lin,
Kai Yin,
Weiqiang Yin,
Jinsong Lu
Publication year - 2019
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm.2019.04.26
Subject(s) - taxane , breast cancer , single nucleotide polymorphism , oncology , odds ratio , medicine , genotype , biology , docetaxel , anthracycline , chemotherapy , cancer , cancer research , gene , genetics